Epidermal necrolysis in the context of immuno‐oncologic medication as well as kinase inhibitors and biologics-Reference-Cited by-同舟云学术

Epidermal necrolysis in the context of immuno‐oncologic medication as well as kinase inhibitors and biologics

Published:2022-06 Issue:6 Volume:20 Page:777-786
ISSN:1610-0379
Container-title:JDDG: Journal der Deutschen Dermatologischen Gesellschaft
language:de
Short-container-title:J Deutsche Derma Gesell

Author:

Ziemer Mirjana¹,Fries Viviane²,Paulmann Maren²,Mockenhaupt Maja²

Affiliation:

1. Department of Dermatology Venereology and Allergology University Hospital Leipzig Germany

2. German Center for the Documentation of Severe Skin Reactions (dZh) Department of Dermatologie Medical Center and Medical Faculty ‐ University of Freiburg Germany

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ddg.14711

Reference50 articles.

1. Incidence of Epidermal Necrolysis: Results of the German Registry

2. Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-Study

3. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel

4. Risk estimates for drugs suspected of being associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control study

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dermatologische unerwünschte Arzneimittelwirkungen bei Behandlung mit Biologika – Pathogenese und Management;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2024-08

2. Dermatologic adverse events caused by biologic treatments – Pathogenesis and management;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2024-06-25

3. Toxische epidermale Nekrolyse nach Apalutamid mit vorheriger Gabe von Tislelizumab bei einem Patienten mit zwei Krebsarten;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2023-10

4. Case Report: sintilimab-induced Stevens-Johnson Syndrome in a patient with advanced lung adenocarcinoma;Frontiers in Oncology;2023-09-14

5. Toxic epidermal necrolysis post apalutamide with preceding tislelizumab administration in a patient with two cancers;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2023-08-31